{"id":464780,"date":"2024-10-20T10:36:52","date_gmt":"2024-10-20T10:36:52","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-iso-286202020\/"},"modified":"2024-10-26T19:34:14","modified_gmt":"2024-10-26T19:34:14","slug":"bs-iso-286202020","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-iso-286202020\/","title":{"rendered":"BS ISO 28620:2020"},"content":{"rendered":"

This document specifies essential requirements and related test methods for non-electrically driven portable infusion devices, thereafter called \u201cdevice\u201d.<\/p>\n

It is applicable to devices designed for continuous (fixed or adjustable) flow and\/or for bolus neuraxial and intravascular or hypodermic applications.<\/p>\n

\n
\n NOTE\n <\/div>\n

Sites for the neuraxial application include the spine, intrathecal or subarachnoid space, ventricles of the brain and the epi-, extra- or peri-dural space. Neuraxial application anaesthetics can be administered regionally, affecting a large part of the body, such as a limb, and include plexus blocks, such as the branchial plexus blocks or single nerve blocks. Neuraxial application procedures include continuous infusion of wounds with local anaesthetic agents.<\/p>\n<\/div>\n

These devices can be used in health care and non-health care settings. They can be applied or administered by health care professionals or by the intended patient.<\/p>\n

These devices can be pre-filled by the manufacturer or filled before use by a health care professional or the intended patient.<\/p>\n

This document does not apply to<\/p>\n